Oxymetazoline as a predictor of turbinate reduction surgery outcomes: Objective support from a prospective, single-blinded, computational fluid dynamics study.
Zachary T RootZhenxing WuThomas J LepleyAspen R SchnellerRobbie J ChapmanVeronica L FormanekKathleen M KellyBradley A OttoKai ZhaoPublished in: International forum of allergy & rhinology (2024)
We present the first objective evidence that the "topical decongestant test" can help predict turbinate reduction surgery outcomes. The predictive effect is driven by similar improvementin regional airflow that leading to improved air/mucosa stimulations (peak heat flux) rather than through reduced nasal resistance.